Stanford Medicine
A

What You Need to Know About The New Obesity Medications

By Stanford Medicine FEATURING Aaron Yeoh
By Stanford Medicine FEATURING Aaron Yeoh
1,388 views
June 1, 2024
2 Comments
Login to view comments. Click here to Login

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Related Content

AUTOPLAY
47:11
Houston Methodist

The Protein Myth: Our Obsession With Protein and How It Is Killing US

Feat. G. Davis
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
19:55
Cleveland Clinic Taussig Cancer Institute

Exercise, Weight Loss, and Breast Cancer Risk: The Importance of BMI

Feat. A. Guthrie
34:49
Scripps Health

Medications for Weight Loss: The New Satiety Hormones

Feat. K. Fujioka
18:43
ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo
15:06
Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

12:26
Juan Frias

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

40:48
Michigan Medicine

Incretin-based Therapies in the Management of Obesity and its Comorb…

Feat. A. Rothberg
27:24
Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Feat. L. Sloan
15:33
Ken Fujioka

Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…

26:49
Diana Isaacs

Tirzepatide Updates

08:35
Susan Brian

Labs to Check on Semaglutide or Tirzepatide

26:32
Practical Ways to Achieve Targets in Diabetes Care

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Feat. S. Nissen
20:24
Diana Isaacs

Tirzepatide for Type 2 Diabetes

07:41
Susan Brian

Weightloss in Menopause

44:41
Norman Lepor

Obesity: New Understanding and Treatments

06:31
Susan Brian

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

05:08
Susan Brian

The Differences Between the Products of GLP1's and GLP/GIPs

32:17
University of Miami

New Treatments for Steatotic Liver Disease (SLD): Are We There Yet?

Feat. S. A. Harrison
26:57
Houston Methodist

Endoscopic Weight Loss Therapies - A Paradigm Shift in the Treatment…

Feat. T. R. Mccarty